Literature DB >> 23079898

Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease.

Ilan Dar-Nimrod1, Benjamin P Chapman, Peter Franks, John Robbins, Anton Porsteinsson, Mark Mapstone, Paul R Duberstein.   

Abstract

OBJECTIVES: We tested the hypothesis that neuroticism moderates the association between APOE (apolipoprotein E) genotype and two major outcomes, cognitive function and Alzheimer disease. We also explored whether other personality dimensions (extraversion, openness to experience, agreeableness, and conscientiousness) moderate the associations of APOE with these outcomes.
DESIGN: Primary analyses of existing randomized clinical trial data. SAMPLE: Six-hundred two older adults (mean age of 78 years at baseline). MEASUREMENTS: APOE genotype, the NEO-Five Factor Inventory, the Alzheimer's Disease Assessment Scale-Cognitive: measured every 6 months for 6.5 years) and relevant covariates.
RESULTS: Fully adjusted multivariate analyses showed that the association between the presence of APOE [Latin Small Letter Open E]-4 allele(s) and both outcomes was evident among individuals with high levels of neuroticism and extraversion but not among persons with low levels of these traits.
CONCLUSIONS: Phenotypic personality dimensions, primarily neuroticism and extraversion, moderate the relationship between APOE [Latin Small Letter Open E]-4 genotype and cognitive outcomes among older adults. Future research is needed to elucidate the physiological processes involved in these particular phenotype-genotype interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079898      PMCID: PMC4184145          DOI: 10.1097/JGP.0b013e318267016b

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  42 in total

1.  Cognitive activity and incident AD in a population-based sample of older persons.

Authors:  R S Wilson; D A Bennett; J L Bienias; N T Aggarwal; C F Mendes De Leon; M C Morris; J A Schneider; D A Evans
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

2.  Increased CSF cortisol in AD is a function of APOE genotype.

Authors:  E R Peskind; C W Wilkinson; E C Petrie; G D Schellenberg; M A Raskind
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

3.  Personality change during depression treatment: a placebo-controlled trial.

Authors:  Tony Z Tang; Robert J DeRubeis; Steven D Hollon; Jay Amsterdam; Richard Shelton; Benjamin Schalet
Journal:  Arch Gen Psychiatry       Date:  2009-12

4.  The effects of the transcendental mediation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults.

Authors:  C Gaylord; D Orme-Johnson; F Travis
Journal:  Int J Neurosci       Date:  1989-05       Impact factor: 2.292

5.  Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D)

Authors:  M Irwin; K H Artin; M N Oxman
Journal:  Arch Intern Med       Date:  1999 Aug 9-23

6.  Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

Authors:  L H Kuller; L Shemanski; T Manolio; M Haan; L Fried; N Bryan; G L Burke; R Tracy; R Bhadelia
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

7.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

8.  An 18-year follow-up of overweight and risk of Alzheimer disease.

Authors:  Deborah Gustafson; Elisabet Rothenberg; Kaj Blennow; Bertil Steen; Ingmar Skoog
Journal:  Arch Intern Med       Date:  2003-07-14

9.  The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

Authors:  D R Gustafson; L Melchior; E Eriksson; V Sundh; K Blennow; I Skoog
Journal:  Neurobiol Aging       Date:  2008-10-05       Impact factor: 4.673

10.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

View more
  12 in total

Review 1.  Personality and Incident Alzheimer's Disease: Theory, Evidence, and Future Directions.

Authors:  Suzanne C Segerstrom
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-02-14       Impact factor: 4.077

2.  Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.

Authors:  Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk
Journal:  Am J Geriatr Psychiatry       Date:  2015-02-11       Impact factor: 4.105

3.  Facets of Conscientiousness and risk of dementia.

Authors:  A R Sutin; Y Stephan; A Terracciano
Journal:  Psychol Med       Date:  2017-09-06       Impact factor: 7.723

4.  Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

Authors:  Shanna L Burke; Janice O'Driscoll; Amary Alcide; Tan Li
Journal:  Int J Geriatr Psychiatry       Date:  2016-11-02       Impact factor: 3.485

Review 5.  Personality and Alzheimer's disease: An integrative review.

Authors:  Antonio Terracciano; Angelina R Sutin
Journal:  Personal Disord       Date:  2019-01

6.  Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults.

Authors:  Shraddha Sapkota; Sandra A Wiebe; Brent J Small; Roger A Dixon
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-07       Impact factor: 3.485

7.  The Relation Between Personality and Biomarkers in Sensitivity and Conversion to Alzheimer-Type Dementia.

Authors:  Janet M Duchek; Andrew J Aschenbrenner; Anne M Fagan; Tammie L S Benzinger; John C Morris; David A Balota
Journal:  J Int Neuropsychol Soc       Date:  2019-12-11       Impact factor: 2.892

8.  Sociodemographic, Medical, and Psychosocial Factors Associated With Supportive Care Needs in Adults Diagnosed With Uveal Melanoma.

Authors:  Timothy J Williamson; Alexandra Jorge-Miller; Tara A McCannel; Tammy M Beran; Annette L Stanton
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

9.  Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.

Authors:  Domilė Tautvydaitė; Deepti Kukreja; Jean-Philippe Antonietti; Hugues Henry; Armin von Gunten; Julius Popp
Journal:  Alzheimers Res Ther       Date:  2017-02-02       Impact factor: 6.982

10.  Common genetic variation of the APOE gene and personality.

Authors:  Christian Montag; Lukas Kunz; Nikolai Axmacher; Rayna Sariyska; Bernd Lachmann; Martin Reuter
Journal:  BMC Neurosci       Date:  2014-05-20       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.